{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:12:02Z","timestamp":1778339522533,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45051-w","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:46:21Z","timestamp":1774068381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting STAT3 pathway attenuates macrophages inflammation and cardiovascular injury in a model of Kawasaki disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Fenglei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"17","key":"45051_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle, B. W. et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation 135 (17), e927\u2013e999 (2017).","journal-title":"Circulation"},{"issue":"6","key":"45051_CR2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","volume":"94","author":"H Kato","year":"1996","unstructured":"Kato, H. et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94 (6), 1379\u20131385 (1996).","journal-title":"Circulation"},{"issue":"23","key":"45051_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"PN Jone","year":"2024","unstructured":"Jone, P. N. et al. Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association. Circulation 150 (23), 481\u2013500 (2024).","journal-title":"Circulation"},{"issue":"6","key":"45051_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/1358863X19878495","volume":"24","author":"R Ohashi","year":"2019","unstructured":"Ohashi, R. et al. M1 macrophage is the predominant phenotype in coronary artery lesions following Kawasaki disease. Vasc Med. 24 (6), 484\u2013492 (2019).","journal-title":"Vasc Med."},{"issue":"8","key":"45051_CR5","doi-asserted-by":"publisher","first-page":"e1412","DOI":"10.1002\/cti2.1412","volume":"11","author":"AT Stock","year":"2022","unstructured":"Stock, A. T. et al. Intimal macrophages develop from circulating monocytes during vasculitis. Clin. Transl Immunol. 11 (8), e1412 (2022).","journal-title":"Clin. Transl Immunol."},{"key":"45051_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fped.2020.00129","volume":"8","author":"MM Guo","year":"2020","unstructured":"Guo, M. M., Chang, L. S., Huang, Y. H., Wang, F. S. & Kuo, H. C. Epigenetic Regulation of Macrophage Marker Expression Profiles in Kawasaki Disease. Front. Pediatr. 8, 129 (2020).","journal-title":"Front. Pediatr."},{"issue":"6","key":"45051_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/art.1780280609","volume":"28","author":"TJ Lehman","year":"1985","unstructured":"Lehman, T. J., Walker, S. M., Mahnovski, V. & McCurdy, D. Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum. 28 (6), 652\u2013659 (1985).","journal-title":"Arthritis Rheum."},{"issue":"5","key":"45051_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/ATVBAHA.115.307072","volume":"36","author":"D Wakita","year":"2016","unstructured":"Wakita, D. et al. Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm. Arterioscler. Thromb. Vasc Biol. 36 (5), 886\u2013897 (2016).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"45051_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2147\/JIR.S297131","volume":"14","author":"F Zheng","year":"2021","unstructured":"Zheng, F. et al. KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease. J. Inflamm. Res. 14, 719\u2013735 (2021).","journal-title":"J. Inflamm. Res."},{"issue":"Pt 2","key":"45051_CR10","doi-asserted-by":"publisher","first-page":"113523","DOI":"10.1016\/j.intimp.2024.113523","volume":"143","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. A novel STAT3 CCD inhibitor for suppressing macrophage activation and lipopolysaccharide-induced acute lung injury. Int. Immunopharmacol. 143 (Pt 2), 113523 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"45051_CR11","doi-asserted-by":"publisher","first-page":"112221","DOI":"10.1016\/j.intimp.2024.112221","volume":"135","author":"L Cao","year":"2024","unstructured":"Cao, L. et al. The STAT3 inhibitor B9 alleviates lipopolysaccharide-induced acute lung injury through its anti-inflammatory effects. Int. Immunopharmacol. 135, 112221 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"45051_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2015.08.014","volume":"87","author":"Z Qin","year":"2015","unstructured":"Qin, Z. et al. Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3. J. Mol. Cell. Cardiol. 87, 160\u2013170 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"45051_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41419-020-2326-2","volume":"11","author":"QY Wu","year":"2020","unstructured":"Wu, Q. Y. et al. A novel STAT3 inhibitor attenuates angiotensin II-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy. Cell. Death Dis. 11 (2), 131 (2020).","journal-title":"Cell. Death Dis."},{"key":"45051_CR14","doi-asserted-by":"publisher","first-page":"107289","DOI":"10.1016\/j.phrs.2024.107289","volume":"206","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Equisetin protects from atherosclerosis in vivo by binding to STAT3 and inhibiting its activity. Pharmacol. Res. 206, 107289 (2024).","journal-title":"Pharmacol. Res."},{"issue":"16","key":"45051_CR15","first-page":"3714","volume":"21","author":"XL Qi","year":"2017","unstructured":"Qi, X. L. et al. 1,25-Dihydroxyvitamin D3 regulates T lymphocyte proliferation through activation of P53 and inhibition of ERK1\/2 signaling pathway in children with Kawasaki disease. Eur. Rev. Med. Pharmacol. Sci. 21 (16), 3714\u20133722 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"45051_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1538\/expanim.19-0124","volume":"69","author":"E Suganuma","year":"2020","unstructured":"Suganuma, E., Sato, S., Honda, S. & Nakazawa, A. A novel mouse model of coronary stenosis mimicking Kawasaki disease induced by Lactobacillus casei cell wall extract. Exp. Anim. 69 (2), 233\u2013241 (2020).","journal-title":"Exp. Anim."},{"issue":"7","key":"45051_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas, M. & Arditi, M. Kawasaki disease: pathophysiology and insights from mouse models. Nat. Rev. Rheumatol. 16 (7), 391\u2013405 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"45051_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jpeds.2021.12.035","volume":"243","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I\/IIa Trial. J. Pediatr. 243, 173\u2013180 (2022).","journal-title":"J. Pediatr."},{"key":"45051_CR19","doi-asserted-by":"publisher","first-page":"10991","DOI":"10.2147\/JIR.S479879","volume":"17","author":"J Ling","year":"2024","unstructured":"Ling, J. et al. Case Series on the Efficacy and Safety of Tocilizumab in IVIG-Resistant Kawasaki Disease: A Retrospective Analysis of Five Patients. J. Inflamm. Res. 17, 10991\u201310998 (2024).","journal-title":"J. Inflamm. Res."},{"key":"45051_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijcard.2018.04.062","volume":"271","author":"Y Nagatomo","year":"2018","unstructured":"Nagatomo, Y. et al. Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease. Int. J. Cardiol. 271, 317\u2013321 (2018).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"45051_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12964-024-01841-1","volume":"22","author":"SH Lee","year":"2024","unstructured":"Lee, S. H. et al. STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation. Cell. Commun. Signal. 22 (1), 476 (2024).","journal-title":"Cell. Commun. Signal."},{"issue":"6","key":"45051_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41419-021-03852-z","volume":"12","author":"C Jia","year":"2021","unstructured":"Jia, C. et al. IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway. Cell. Death Dis. 12 (6), 575 (2021).","journal-title":"Cell. Death Dis."},{"issue":"6","key":"45051_CR23","doi-asserted-by":"publisher","first-page":"e13251","DOI":"10.1111\/cpr.13251","volume":"55","author":"Y Zheng","year":"2022","unstructured":"Zheng, Y. et al. Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease. Cell. Prolif. 55 (6), e13251 (2022).","journal-title":"Cell. Prolif."},{"issue":"22","key":"45051_CR24","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.7150\/thno.35528","volume":"9","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis. Theranostics 9 (22), 6424\u20136442 (2019).","journal-title":"Theranostics"},{"key":"45051_CR25","doi-asserted-by":"publisher","first-page":"116313","DOI":"10.1016\/j.biopha.2024.116313","volume":"172","author":"B Guo","year":"2024","unstructured":"Guo, B. et al. Targeting the JAK2\/STAT3 signaling pathway with natural plants and phytochemical ingredients: A novel therapeutic method for combatting cardiovascular diseases. Biomed. Pharmacother. 172, 116313 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"45051_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2018.02.022","volume":"271","author":"M Zhai","year":"2018","unstructured":"Zhai, M. et al. Ursolic acid prevents angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice. Atherosclerosis 271, 128\u2013135 (2018).","journal-title":"Atherosclerosis"},{"issue":"5","key":"45051_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/15385744231152961","volume":"57","author":"R Patel","year":"2023","unstructured":"Patel, R. et al. Signaling through the IL-6-STAT3 Pathway Promotes Proteolytically-Active Macrophage Accumulation Necessary for Development of Small AAA. Vasc Endovascular Surg. 57 (5), 433\u2013444 (2023).","journal-title":"Vasc Endovascular Surg."},{"issue":"3","key":"45051_CR28","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/ATVBAHA.119.313863","volume":"40","author":"RA Porritt","year":"2020","unstructured":"Porritt, R. A. et al. Interleukin-1 Beta-Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment. Arterioscler. Thromb. Vasc Biol. 40 (3), 802\u2013818 (2020).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"45051_CR29","doi-asserted-by":"publisher","first-page":"630196","DOI":"10.3389\/fimmu.2021.630196","volume":"12","author":"RA Porritt","year":"2021","unstructured":"Porritt, R. A. et al. Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis. Front. Immunol. 12, 630196 (2021).","journal-title":"Front. Immunol."},{"issue":"4","key":"45051_CR30","doi-asserted-by":"publisher","first-page":"e70152","DOI":"10.1002\/mco2.70152","volume":"6","author":"MA Samad","year":"2025","unstructured":"Samad, M. A. et al. STAT3 Signaling Pathway in Health and Disease. MedComm 6 (4), e70152 (2025).","journal-title":"MedComm"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45051-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45051-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45051-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:02:59Z","timestamp":1778338979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45051-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45051"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45051-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14358"}}